7 results
Indications for tPA in Stroke:
 • Clinical diagnosis of ischemic stroke
 • Measurable neurologic deficit
 •
in Stroke: • Clinical ... diagnosis of ischemic ... • Therapeutic anticoagulation ... #tPA #Stroke #cva ... #management #neurology
Restarting Anticoagulation after TIA or Acute Ischemic Stroke

 • TIA → Consider (re-) starting a NOAC
Restarting Anticoagulation ... after TIA or Acute Ischemic ... worsening or clinical ... #TIA #Stroke #CVA ... #neurology #management
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE) Clinical ... Lumbar Puncture, EEG ... prevention (statin for CVA ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management
Management of Jehovah's Witness patient in ICU 

Clarify which products may be used 
 - Discuss
Management of Jehovah's ... Witness patient in ICU ... - When anticoagulation ... #CriticalCare # ... Management
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
transplantation CLINICAL ... specific therapy, the clinician ... intensive care unit (ICU ... Syndrome #diagnosis #management ... #neurology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
history of: a) Ischemic ... b) CHF c) CVA ... Change in clinical ... Anticoagulation ... medical and surgical management
Statin Induced Muscle Toxicity - Summary

Clinical Presentation:
 • Elevations of serum creatine kinase with proximal myalgia
Toxicity - Summary Clinical ... myopathy, Guillain-Barré ... /I • SAMS clinical ... (SAMS-CI) • EMG ... myopathy #diagnosis #management